SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-080202
Filing Date
2022-07-15
Accepted
2022-07-15 16:05:18
Documents
13
Period of Report
2022-07-15
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2220875d1_8k.htm   iXBRL 8-K 31516
  Complete submission text file 0001104659-22-080202.txt   251186

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eqrx-20220715.xsd EX-101.SCH 3844
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eqrx-20220715_def.xml EX-101.DEF 26951
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eqrx-20220715_lab.xml EX-101.LAB 38148
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eqrx-20220715_pre.xml EX-101.PRE 25573
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2220875d1_8k_htm.xml XML 5587
Mailing Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139 6173152266
EQRx, Inc. (Filer) CIK: 0001843762 (see all company filings)

IRS No.: 861691173 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40312 | Film No.: 221086348
SIC: 2834 Pharmaceutical Preparations